Trial Site Detail

 

Drug:
Sunitinib + TH-302
Trial:
Dose-Escalation Study of TH-302 in Combination With Sunitinib to Treat Patients With Advanced Renal Cell Carcinoma and Gastrointestinal Stromal Tumors (TH-CR-410)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Unknown

 

UI Health Goshen Center for Cancer Care

     
Goshen , IN 46526
USA

 

Principal Investigator:
 Alexander Starodub, MD
Contact:
 Rebecca Eickhoff 574-364-2649 reickhoff@iuhealth.org
Activation Status of this Site:
 Closed
Notes about this Site:
UI Health Goshen Center for Cancer Care Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.